Literature DB >> 29516499

MiR-483-5p and miR-139-5p promote aggressiveness by targeting N-myc downstream-regulated gene family members in adrenocortical cancer.

Claire Agosta1,2,3,4, Jonathan Laugier2,3,4, Laurent Guyon2,3,4, Josiane Denis2,3,4, Jérôme Bertherat5,6,7, Rossella Libé5,6,7, Bruno Boisson8, Nathalie Sturm8, Jean-Jacques Feige2,3,4, Olivier Chabre1,2,3,4, Nadia Cherradi2,3,4.   

Abstract

Adrenocortical carcinoma (ACC) is a tumor with poor prognosis in which overexpression of a panel of microRNAs has been associated with malignancy but a very limited number of investigations on their role in ACC pathogenesis have been conducted. We examined the involvement of miR-483-5p and miR-139-5p in adrenocortical cancer aggressiveness. Using bioinformatics predictions and mRNA/miRNA expression profiles, we performed an integrated analysis to identify inversely correlated miRNA-mRNA pairs in ACC. We identified N-myc downstream-regulated gene family members 2 and 4 (NDRG2 and NDRG4) as targets of miR-483-5p and miR-139-5p, respectively. NDRG2 and NDRG4 expressions were inversely correlated respectively with miR-483-5p and miR-139-5p levels in aggressive ACC samples from two independent cohorts of 20 and 44 ACC. Moreover, upregulation of miR-139-5p and downregulation of NDRG4 demonstrated a striking prognostic value. A direct interaction between miR-483-5p or miR-139-5p and their targets was demonstrated in reporter assays. Downregulation of miR-483-5p or miR-139-5p in the ACC cell lines NCI-H295R and SW13 increased NDRG2 or NDRG4 mRNA and protein expression, compromised adrenocortical cancer cell invasiveness and anchorage-independent growth. MiR-483-5p or miR-139-5p overexpression and NDRG2 or NDRG4 inhibition produce similar changes, which are rescued by NDRG2 or NDRG4 ectopic expression. We established that key factors mediating epithelial-to-mesenchymal transition are downstream effectors of miR-483-5p/NDRG2 and miR-139-5p/NDRG4 pathways. Collectively, our data show for the first time that miR-483-5p/NDRG2 and miR-139-5p/NDRG4 axes promote ACC aggressiveness, with potential implications for prognosis and therapeutic interventions in adrenocortical malignancies.
© 2018 UICC.

Entities:  

Keywords:  N-myc downstream-regulated gene family; NDRG2; NDRG4; adrenocortical cancer; invasion; miR-139-5p; miR-483-5p

Mesh:

Substances:

Year:  2018        PMID: 29516499     DOI: 10.1002/ijc.31363

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

1.  Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma.

Authors:  Bin Yu; Youming Ding; Xiaofeng Liao; Changhua Wang; Bin Wang; Xiaoyan Chen
Journal:  Dig Dis Sci       Date:  2019-04-04       Impact factor: 3.199

2.  MicroRNA-483-5p accentuates cisplatin-induced acute kidney injury by targeting GPX3.

Authors:  Ying Xia; Wenbin Pan; Xiao Xiao; Xuejuan Zhou; Wenqing Gu; Yaqin Liu; Yanyan Zhao; Lixia Li; Chenghao Zheng; Jun Liu; Ming Li
Journal:  Lab Invest       Date:  2022-02-18       Impact factor: 5.662

3.  Targeted Disruption of Lats1 and Lats2 in Mice Impairs Adrenal Cortex Development and Alters Adrenocortical Cell Fate.

Authors:  Amélie Ménard; Nour Abou Nader; Adrien Levasseur; Guillaume St-Jean; Marie Le Gad- Le Roy; Derek Boerboom; Marie-Odile Benoit-Biancamano; Alexandre Boyer
Journal:  Endocrinology       Date:  2020-05-01       Impact factor: 4.736

4.  Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases.

Authors:  Mark J McCabe; Mark Pinese; Chia-Ling Chan; Nisa Sheriff; Tanya J Thompson; John Grady; Marie Wong; Marie-Emilie A Gauthier; Clare Puttick; Velimir Gayevskiy; Elektra Hajdu; Stephen Q Wong; Wade Barrett; Peter Earls; Robyn Lukeis; Yuen Y Cheng; Ruby C Y Lin; David M Thomas; D Neil Watkins; Marcel E Dinger; Ann I McCormack; Mark J Cowley
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-04-01

5.  MicroRNA suppression of stress-responsive NDRG2 during dexamethasone treatment in skeletal muscle cells.

Authors:  Bilal A Mir; Rabia Islam; Ming Kalanon; Aaron P Russell; Victoria C Foletta
Journal:  BMC Mol Cell Biol       Date:  2019-05-28

6.  The New Biomarker for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Based on Public Database Mining.

Authors:  Hao Ding; Xiao-Xing Xiong; Guan-Lan Fan; Yue-Xiong Yi; Yu-Rou Chen; Jing-Tao Wang; Wei Zhang
Journal:  Biomed Res Int       Date:  2020-04-12       Impact factor: 3.411

7.  Differential Expression Profiles of Cell-to-Matrix-Related Molecules in Adrenal Cortical Tumors: Diagnostic and Prognostic Implications.

Authors:  Marco Volante; Ida Rapa; Jasna Metovic; Francesca Napoli; Cristian Tampieri; Eleonora Duregon; Massimo Terzolo; Mauro Papotti
Journal:  J Pers Med       Date:  2021-05-06

8.  IGF2-derived miR-483-3p associated with Hirschsprung's disease by targeting FHL1.

Authors:  Zhengke Zhi; Hairong Zhu; Xiaofeng Lv; Changgui Lu; Yang Li; Feng Wu; Lingling Zhou; Hongxing Li; Weibing Tang
Journal:  J Cell Mol Med       Date:  2018-08-02       Impact factor: 5.310

9.  Circulating miR-19a-3p and miR-483-5p as Novel Diagnostic Biomarkers for the Early Diagnosis of Gastric Cancer.

Authors:  Jieyao Cheng; Aiming Yang; Shujun Cheng; Lin Feng; Xi Wu; Xinghua Lu; Ming Zu; Jianfang Cui; Hang Yu; Long Zou
Journal:  Med Sci Monit       Date:  2020-06-03

10.  MiR-139-5p influences hepatocellular carcinoma cell invasion and proliferation capacities via decreasing SLITRK4 expression.

Authors:  Jisiguleng Wu; Tong Zhang; Yubo Chen; Sigaowa Ha
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.